New Parkinson's shot enters first human safety tests
Disease control
Recruiting now
This is a first-in-human study to check the safety and how the body processes a new single-injection drug called SER-252. It is for people with Parkinson's disease who experience daily 'off' periods where their medication wears off and symptoms return. The study will give increas…
Phase: PHASE1 • Sponsor: Serina Therapeutics • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC